Welcome to TRANS-INT
TRANS-INT - New oral nanomedicines: Transporting therapeutic macromolecules across the intestinal barrier
This is a large-scale collaborative research project within the 7th European Framework Programme for Research and Technological Development. The TRANS-INT project will run from May 1st, 2012 to April 30th, 2017.
In TRANS-INT a clear concept and shared ambition provide the cohesive force. The concept behind TRANS-INT is the rational design of oral nanomedicines based on safety, mechanistic, bioengineering and pharmaceutical technology criteria.
The consortium is composed of 16 partners from industry and academia with complementary leading expertise in chemistry, chemical engineering, pharmaceutical technology, molecular physiology, biopharmaceutics, toxicology and drug development.